Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of uveitis.

J R Bierly1, R A Nozik

  • 1The Francis I. Proctor Foundation, University of California at San Francisco.

Current Opinion in Ophthalmology
|July 7, 1992
PubMed
Summary
This summary is machine-generated.

Uveitis management often uses steroids, but infections require specific antimicrobials, especially in immunosuppressed patients. Diagnostic tools like antibody analysis and biopsy aid in specific etiologic diagnosis for better uveitis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presumed Sympathetic Ophthalmia Following Nd: YAG Transscleral Cyclophotocoagulation.

Journal of glaucoma·2009
Same author

Corneal topographic changes after extraocular muscle surgery.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·1999
Same author

Vogt-Koyanagi-Harada syndrome after cutaneous injury.

Ophthalmology·1999
Same author

Clinical assessment of the piggyback bifocal contact lens system.

The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc·1999
Same author

Vogt-Koyanagi-Harada syndrome in children.

Ocular immunology and inflammation·1998
Same author

Uveitis associated with an epidemic outbreak of leptospirosis.

American journal of ophthalmology·1997
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Immunology
  • Infectious Diseases

Background:

  • Uveitis management primarily relies on non-specific topical, periocular, and systemic steroids.
  • Infectious uveitis, particularly in immunosuppressed patients, necessitates specific antimicrobial agents due to atypical and severe presentations.
  • Diagnosing and managing complex uveitis cases remains a challenge.

Purpose of the Study:

  • To review current and emerging strategies for uveitis management.
  • To highlight the importance of specific etiologic diagnosis in uveitis.
  • To discuss diagnostic tools and therapeutic options for various uveitis types.

Main Methods:

  • Review of literature on uveitis management.
  • Analysis of diagnostic approaches including local antibody production and chorioretinal biopsy.

Related Experiment Videos

  • Discussion of therapeutic agents, including steroids, antimicrobials, cytotoxic agents, and newer immunosuppressives.
  • Main Results:

    • Infectious uveitis requires specific antimicrobial therapy.
    • Analysis of local antibody production can aid diagnosis.
    • Chorioretinal biopsy provides specific etiologic diagnosis.
    • Newer immunosuppressives like cyclosporine and FK-506 may offer improved safety profiles.
    • The role of posterior chamber lens implantation in uveitis patients is evolving.

    Conclusions:

    • Specific etiologic diagnosis is crucial for effective uveitis management, especially in infectious or severe endogenous cases.
    • A combination of diagnostic tools and tailored therapeutic strategies, including newer immunosuppressives, is essential.
    • Further research is needed to refine treatment protocols and understand the long-term implications of interventions like lens implantation.